Table 2: Levels of resistance and resistance mutation scores among protease inhibitors, nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors and integrase strand transfer inhibitors in all tests conducted among 66 treatment-naïve patients and 43 treatment experienced patients